Treatment of familial hypertriglyceridaemia with acarbose

Diabetes, Obesity and Metabolism

Volumn 2, Issue 1, 2000, Pages 33-38

  Malaguarnera, M ^a   Giugno, I ^a   Ruello, P ^a   Maugeri, D ^a   Pistone, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Acarbose; Hypertriglyceridaemia; Lipids

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; CHOLESTEROL; FIBRIC ACID DERIVATIVE; FISH OIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTESTINE ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; OMEGA 3 FATTY ACID; PLACEBO; STARCH; TRIACYLGLYCEROL;

ADULT; AGED; APPETITE DISORDER; ARTHRALGIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPETITIVE INHIBITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DIARRHEA; DIET RESTRICTION; DIET THERAPY; DIGESTIVE SYSTEM FUNCTION DISORDER; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EPIGASTRIC PAIN; EVALUATION; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; FRIGIDITY; GALLSTONE FORMATION; GASTROINTESTINAL DISEASE; GLUCAGON BLOOD LEVEL; HEART ARRHYTHMIA; HEARTBURN; HEPATOMEGALY; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOTENSION; IMPOTENCE; KIDNEY DISEASE; MALE; MEAL; MYALGIA; NAUSEA; PILL; RANDOMIZED CONTROLLED TRIAL; RASH; RISK FACTOR; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

EID: 0034534595     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2000.00065.x     Document Type: Article

References (26)

1. Plasma triglyceride level as risk factor for cardiovascular disease independent of high density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies
2. Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia
3. Myocardial infarction in the familial forms of hypertriglyceridemia
4. Suppression by diets rich in fish oil of very low density lipoprotein production in men
5. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus
6. Pharmacology of alpha-glucosidase inhibitors
7. Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM: A placebo-controlled dose-comparison study
8. Beneficial effects on serum lipids in non-insulin dependent diabetics by acarbose treatment
9. Acarbose: A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential
10. The effects of the α-glucosidase inhibitor BAY g5421 (acarbose) on post-prandial blood glucose, serum insulin, and triglyceride levels: Dose-time response relationship in man
11. Changes in plasma lipoprotein levels during medication with a glucosidase-hydrolase inhibitor (acarbose)
12. Inhibition of carbohydrate-induced hypertriglyceridemia by a disaccharidase inhibitor
13. Risk factors for coronary artery disease in healthy people with hyper-insulinemia and normal glucose tolerance
14. Beneficial effects of acarbose on familiar hypertriglyceridemias
15. Enzymatische Bestimmung des Gesamtcholesterins in Serum
16. Triglycerides determination after enzymatic hydrolysis
17. Cholesterol determination in high density lipoproteins separated by three different methods
18. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions
19. Index of coronary artery atherogenesis
20. Serum triglycerides in coronary artery disease
21. Relation of triglyceride metabolism and coronary artery disease: Studies in the postprandial state
22. Postprandial hyperlipidemia and remnant lipoproteins
23. Plasma triglyceride level and mortality from coronary heart disease
24. Risk factors for death for males and females: A study of death pattern in the Stockholm Prospective Study
25. Retest reliability of plasma cholesterol and triglyceride: The Lipid Research Clinic Prevalence Study
26. Acarbose is an effective adjunct to dietary therapy in the treatment of hypertriglyceridaemias